NCT03601390View on ClinicalTrials.gov

Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC

CompletedOBSERVATIONAL

Enrollment

387

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 12, 2019

Study Completion Date

December 12, 2020

Conditions

Nasopharyngeal Carcinoma

Interventions

DEVICE

PET/CT and EBV DNA

PET/CT and EBV DNA will be proformed after the IMRT treatment

Trial Locations (1)

510060

Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER

NCT03601390 - Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC | Biotech Hunter | Biotech Hunter